Updated Jul 16, 2026
Hefti Brenda has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.15M.

Brenda Hefti serves as the Senior Vice President and General Counsel at Exelixis, Inc., a biotechnology company focused on developing and commercializing innovative cancer therapies. In her role, she oversees the company's legal affairs, including compliance, corporate governance, and intellectual property matters.
| Role | SVP and General Counsel |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-19 | EXEL | EXELIXIS, INC. | S — Open-market sale | 6.6K | $50.21 | $333K |
| 2026-05-19 | EXEL | EXELIXIS, INC. | F — Tax withholding / forfeiture | 6.4K | $51.10 | $328K |
| 2026-03-03 | EXEL | EXELIXIS, INC. | A — Grant or award | 23.1K | $0.00 | |
| 2026-02-19 | EXEL | EXELIXIS, INC. | S — Open-market sale [10b5-1] | 18.7K | $44.01 | $822K |
| 2026-02-19 | EXEL | EXELIXIS, INC. | F — Tax withholding / forfeiture [10b5-1] | 5.4K | $43.92 | $238K |
Brenda Hefti serves as the Senior Vice President and General Counsel at Exelixis, Inc., a biotechnology company focused on developing and commercializing innovative cancer therapies. In her role, she oversees the company's legal affairs, including compliance, corporate governance, and intellectual property matters.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.15M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hefti Brenda profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.